Last reviewed · How we verify

NCT07092722

Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males

Not yet recruiting NA Last updated 30 July 2025
What this trial tests

NA trial testing LN18178 in Muscle Strength Recovery in 120 participants. Not yet recruiting.

Timeline
4 August 2025
Primary endpoint
15 January 2026
15 January 2026

Quick facts

Lead sponsorGENCOR Lifestage Solutions
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment120
Start date4 August 2025
Primary completion15 January 2026
Estimated completion15 January 2026

Drugs / interventions tested

Conditions studied

Sponsor

GENCOR Lifestage Solutions

Who can join

Adults 36 to 50, male only, with Muscle Strength Recovery or Endurance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Purpose of the study is to evaluate the efficacy of LN18178 in improving muscle strength, aerobic capacity and body composition in healthy young males.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of LN18178

Trials testing the same drug.

Other GENCOR Lifestage Solutions trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07092722.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing